Valuation: iSpecimen Inc.

Market Cap 3.7M 3.19M 3.02M 2.74M 5.14M 354M 5.16M 35.87M 13.79M 180M 13.9M 13.6M 569M P/E 2024
-0.15x
P/E 2025 -0.11x
Enterprise Value -2.91M -2.51M -2.37M -2.15M -4.04M -278M -4.06M -28.19M -10.84M -141M -10.93M -10.69M -447M EV / Sales 2024
0.11x
EV / Sales 2025 -2.11x
Free-Float
99.96%
Yield 2024 *
-
Yield 2025 -
1 day-2.00%
1 week-4.55%
Current month-4.55%
1 month-36.09%
3 months-46.55%
6 months-87.08%
Current year-85.87%
1 week 1.38
Extreme 1.38
1.94
1 month 1.38
Extreme 1.38
2.59
Current year 1.38
Extreme 1.38
18
1 year 1.38
Extreme 1.38
86.4
3 years 1.38
Extreme 1.38
632
5 years 1.38
Extreme 1.38
23,183.92
10 years 1.38
Extreme 1.38
23,183.92
Manager TitleAgeSince
Chief Executive Officer 39 2026-08-25
Director of Finance/CFO 36 2024-12-12
Chief Executive Officer 32 2025-11-06
Director TitleAgeSince
Director/Board Member 31 2024-09-24
Director/Board Member 41 2025-06-19
Director/Board Member 35 2025-11-06
Date Insider Type Main position Quantity % Market Cap. Importance
9/25/24 Free

Chief Executive Officer

168 0.0013%
9/25/24 Free

Chairman

168 0.0013%
9/25/24 Free

Director

168 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%-4.55%-98.12%-99.72% 3.7M
+0.65%-0.81%-2.80%+47.48% 3,680B
+0.83%-4.07%-2.45%+971.99% 402B
+1.55%-1.14%-15.75%+20.01% 79.69B
-0.23%+3.89%+62.06%+126.93% 79.43B
+0.05%+0.90%-6.60%-14.88% 76.15B
-1.35%-5.22%-45.81%+172.20% 65.07B
+0.07%-5.21%+2.76%-13.97% 45.49B
-0.69%+0.36%-12.50%+49.26% 40.29B
-1.64%-2.42%+122.17%+252.04% 34.92B
Average +0.39%-1.83%+0.30%+151.13% 450.32B
Weighted average by Cap. +0.48%-1.11%-1.60%+132.63%

Financials

2024 2025
Net sales 9.29M 8.01M 7.58M 6.87M 12.89M 888M 12.95M 90.03M 34.62M 452M 34.89M 34.13M 1.43B 1.93M 1.66M 1.57M 1.43M 2.68M 184M 2.69M 18.69M 7.19M 93.76M 7.24M 7.09M 296M
Net income -12.5M -10.77M -10.2M -9.24M -17.34M -1.19B -17.43M -121M -46.57M -607M -46.94M -45.91M -1.92B -10.49M -9.04M -8.56M -7.76M -14.55M -1B -14.62M -102M -39.08M -510M -39.39M -38.52M -1.61B
Net Debt -1.57M -1.35M -1.28M -1.16M -2.17M -150M -2.18M -15.18M -5.84M -76.13M -5.88M -5.75M -241M -6.61M -5.7M -5.39M -4.89M -9.17M -632M -9.22M -64.07M -24.64M -321M -24.83M -24.29M -1.02B
Logo iSpecimen Inc.
iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
Employees
7
Date Price Change Volume
26-09-11 $1.470 -2.00% 182,073
26-09-10 $1.500 -3.23% 532,970
26-09-09 $1.550 -2.52% 920,864
26-09-08 $1.590 +3.25% 14,179,923

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ISPC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!